Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 1,868 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02752035	A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy	completed	Phase 3	183	Astellas Pharma Global Development, Inc.INDUSTRY	13	Jul 14, 2026	clinicaltrials
NCT03519971	Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer	completed	Phase 3	328	AstraZenecaINDUSTRY